 |
ARCHIVE # 4: 554 ARTICLES (NOV -SEPT 2006) |
|
|||||
My Educational Video on MS and MS Trials| Visitors Since 03/2006 |
||||||||||||||||||||||||||||||||||||||||
| Click here to read messages from our MySpace Friends HERE'S A FEW OF OUR 1,404 MySpace FRIENDS |
||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||
 Click to view 1280 MS Walk photos! | ||||||||||||||||||||||||||||||||||||||||
| "Join a trial at Barrow & receive all medication & study based procedures at no charge!" | ||||||||||||||||||||||||||||||||||||||||
Stan Swartz, CEO, The MD Health Channel "WE PRODUCED THE FOLLOWING 9 VIDEOS FOR YOU!" Simply click the "video" buttons below: . |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
| Previious Posts | ||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
| MS NEWS ARCHIVES: by week | ||||||||||||||||||||||||||||||||||||||||
| September 2006 | ||||||||||||||||||||||||||||||||||||||||
| October 2006 | ||||||||||||||||||||||||||||||||||||||||
| November 2006 | ||||||||||||||||||||||||||||||||||||||||
| July 2013 | ||||||||||||||||||||||||||||||||||||||||
| April 2014 | ||||||||||||||||||||||||||||||||||||||||
Thursday, November 02, 2006
PRESS RELEASE: BIOMS MEDICAL RECEIVES ADDITIONAL PATENT FOR MULTIPLE SCLEROSIS DRUG MBP8298 IN THE UNITED STATES
Edmonton, Alberta, November 2, 2006 – BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the University of Alberta has received additional patents for the Company’s synthetic peptide therapeutic, MBP8298, for the treatment of multiple sclerosis (MS). BioMS Medical licenses these patents on an exclusive worldwide basis from the University of Alberta.
The most recent patent, entitled “Methods of predicting therapeutic efficacy of treatment of a multiple sclerosis patient” has been granted in the United States and addresses methods of predicting efficacy of certain courses of treatment for MS patients.
“We are pleased about our recent patent protection in the United States. Protection of the Company’s intellectual property, in the United States and throughout the world, represents a key aspect of our commercial development. It also provides a view into the excellent scientific and clinical development supporting this important MS drug.” said Kevin Giese, President and CEO of BioMS Medical.
In total, BioMS has exclusive licenses to 99 granted patents in 34 countries throughout the world. CLICK TO GO TO BIOS MEDICAL HOME PAGE
Edmonton, Alberta, November 2, 2006 – BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the University of Alberta has received additional patents for the Company’s synthetic peptide therapeutic, MBP8298, for the treatment of multiple sclerosis (MS). BioMS Medical licenses these patents on an exclusive worldwide basis from the University of Alberta.
The most recent patent, entitled “Methods of predicting therapeutic efficacy of treatment of a multiple sclerosis patient” has been granted in the United States and addresses methods of predicting efficacy of certain courses of treatment for MS patients.
“We are pleased about our recent patent protection in the United States. Protection of the Company’s intellectual property, in the United States and throughout the world, represents a key aspect of our commercial development. It also provides a view into the excellent scientific and clinical development supporting this important MS drug.” said Kevin Giese, President and CEO of BioMS Medical.
In total, BioMS has exclusive licenses to 99 granted patents in 34 countries throughout the world. CLICK TO GO TO BIOS MEDICAL HOME PAGE